The first strongly suppressed tumor growth of highly expressing ephrin-B2 GSCs orthotopically implanted in mice [11], the latter induced a dose-dependent tumor regression of U251MG and BAH1 cells subcutaneously xenografted mice [8]. This evidence concerns the gene EFNB2 and neoplasm.